Europe will lose out to countries like the U.S. and Japan on new medical research, trials and treatments unless draft rules reforming the European pharmaceutical landscape change, the CEO of Danish drugmaker Novo Nordisk warned on Thursday. The European Commission will present its proposed overhaul of the bloc’s pharmaceuticals regulation on March 29, the first […]
